Analyzing cell cycle-independent effects, we found that MLN4924 prevented the UBE2M-dependent neddylation of cullin 1, as recently observed in renal cell carcinoma [28], while cisplatin induced a strong decrease in proteasome activity, already reported in non-small cell lung cancer cells [29]. The gene discussed is UBE2M; the disease is renal cell carcinoma.